MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Mounjaro

  • Over 700 Drugs More Expensive in 2024, Including Ozempic and Mounjaro
    Over 700 Drugs More Expensive in 2024, Including Ozempic and Mounjaro
    To start 2024, prices hikes on hundreds of drugs are up 22 percent, but record cost savings are expected for Medicaid 
    January 22, 2024BY A.C. Dahnke
  • Eli Lilly to Sell Weight Loss Drugs Directly to Patients
    Eli Lilly to Sell Weight Loss Drugs Directly to Patients
    The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
    January 8, 2024BY A.C. Dahnke
  • FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
    FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
    The FDA is also investigating reported side effects of aspiration.
    January 4, 2024BY A.C. Dahnke
  • How Effective is Weight-Loss Medication vs. Supplements? New Phase of Weight-Loss Meds | Feat. Dr. Damon Noto
    How Effective is Weight-Loss Medication vs. Supplements? New Phase of Weight-Loss Meds | Feat. Dr. Damon Noto
    Dr. Damon Noto discusses the pros and cons of weight loss drugs Ozempic and Mounjaro on VitalSigns.
    October 20, 2023BY Brendon Fallon
  • Diabetes Drug Manufacturers Sued by Woman Who Claims She Suffered ‘Severe Gastrointestinal Events’
    Diabetes Drug Manufacturers Sued by Woman Who Claims She Suffered ‘Severe Gastrointestinal Events’
    The manufacturers of diabetes drugs Ozempic and Mounjaro have been sued by a Louisiana woman who claims they failed to adequately ...
    August 3, 2023BY Katabella Roberts
  • UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
    UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
    UK's health and social care watchdog has decided against recommending Mounjaro, Eli Lilly's weight loss drug for adults with diabetes. ...
    June 28, 2023BY Harry Lee
  • Diabetes Drug Shown to Effectively Trim Fat With Minimal Muscle Loss: Study
    Diabetes Drug Shown to Effectively Trim Fat With Minimal Muscle Loss: Study
    Based on a recent analysis, Mounjaro, an approved medication for Type 2 diabetes, has shown promise in reducing ...
    May 31, 2023BY Harry Lee
TOP NEWS
  • Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
    1hr By T.J. Muscaro
    Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
  • Iran Launches First Missiles at Israel Since Ceasefire Agreement
    2hr By Jacki Thrapp
    Iran Launches First Missiles at Israel Since Ceasefire Agreement
  • Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
    3hr By Jack Phillips
    Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    4hr By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    5hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    6hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
    7hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    11hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
  • US Bankruptcy Filings Increase 7 Percent Yearly
    12hr By Naveen Athrappully
    US Bankruptcy Filings Increase 7 Percent Yearly
  • How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
    13hr By Jacob Burg
    How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top